Article
Serum Alpha-Synuclein and Inflammatory Markers profile in an Egyptian Alzheimer’s and Parkinson’s Diseases patients: A Pilot Study
2024-02-15
Abstract excerpt
<title>Abstract</title> <p>Alzheimer’s and Parkinson's disease are the most common neurodegenerative diseases. In the current study, we explored the potential of blood-based markers to differentiate Alzheimer's disease (AD) and Parkinson's disease (PD) from healthy controls using ELISA assays via measuring the serum level of α-Syn and panels of inflammatory cytokines in the small pilot cohort of Egyptian voluntee...
Topics
Open a Topic to create a Post that cites this publication.
- Alzheimer's disease research and treatments
- Autophagy in Disease and Therapy
- Botulinum Toxin and Related Neurological Disorders
- Clusterin in disease pathology
- Genetic Neurodegenerative Diseases
- Neurological disorders and treatments
- Nuclear Receptors and Signaling
- Parkinson's Disease Mechanisms and Treatments
Identifiers and source
- Literature Corpus work
- 5504a0df-cd08-5a2c-bd65-5c076c488cb0
- DOI
- 10.21203/rs.3.rs-3893418/v1
